to test the hypothesis that gaba activity is a component of antipanic drug efficacy , the authors treated nine medication-free panic disorder subjects with oral baclofen ( 30 mg/day for 4 weeks ) in a double-blind , placebo-controlled crossover trial .
C0016904
gaba
C0004609
baclofen